Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
17 studies found for:    HLA-DRB1
Show Display Options
Rank Status Study
1 Recruiting HLA-DRB1 and HLA-DQB1 Genotyping for Autoantibody-positive and -Negative Patients With Atrophic Glossitis or Burning Mouth Syndrome
Condition: Atrophic Glossitis, Burning Mouth Syndrome
Intervention: Dietary Supplement: Supplementation of vitamin B complex, C, B12, folic acid, Iron and Zinic
2 Completed Hepatitis B Vaccine Genetics: A Substudy of ATN 024 and ATN 025
Conditions: HIV Infection;   Hepatitis B
Intervention:
3 Completed DNA Typing of HLA-DR/DQ Alleles in Taiwan Chinese With Rheumatic Heart Disease
Condition: Rheumatic Heart Disease
Intervention: Procedure: venipuncture to withdraw patient's blood
4 Completed Study of Human Leukocyte Antigen (HLA) Polymorphisms in Patients With Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Intervention: Biological: Collect of 10 ml of peripheric blood for DNA extraction
5 Recruiting Genetic Study of Antithyroid Drugs Associated Agranulocytosis
Condition: Agranulocytosis
Intervention:
6 Completed
Has Results
Clinical Protocol SeCore, uTYPE and 3500 Dx System
Condition: Human Leukocyte Antigens (HLA)
Intervention:
7 Unknown  Sirolimus/Tacrolimus Combination After HLA Matched Related Peripheral Blood Stem Cell Transplants
Conditions: Acute Leukemia in Remission;   Myelodysplastic Syndromes;   Leukemia, Myeloid, Chronic-Phase;   Leukemia, Myeloid, Accelerated-Phase
Interventions: Drug: Sirolimus;   Drug: Tacrolimus
8 Recruiting Randomized HaploCord Blood Transplantation vs. Double Umbilical Cord Blood Transplantation for Hematologic Malignancies
Conditions: Acute Myelogenous Leukemia;   Myelodysplastic Syndrome;   Acute Lymphocytic Leukemia;   Hodgkin's Lymphoma;   Non-Hodgkin's Lymphoma
Interventions: Device: CliniMACS® CD34 Reagent System;   Drug: Fludarabine;   Drug: Melphalan;   Drug: Rabbit ATG;   Procedure: Double Umbilical Cord Blood Transplantation;   Procedure: Haplo-Identical Cord Transplantation
9 Unknown  Randomized Study of ATG for Graft Versus Host Disease (GVHD) Prevention in Paediatric Patients Given an Unrelated Donor Stem Cell Transplantation
Condition: Paediatric Patients Affected by Haematological Malignancies and Eligible to Undergo HSCT From an Unrelated Volunteer
Intervention: Drug: ATG Fresenius
10 Terminated Conditioning Treatment With Umbilical Cord Blood Transplant for Hematologic Malignancies
Condition: Hematologic Malignancies
Interventions: Drug: Fludarabine;   Drug: Busulfan;   Drug: Thymoglobulin;   Radiation: Total Body Irradiation;   Biological: Umbilical Cord Blood
11 Unknown  Therapy Protocol Acute Lymphoblastic Leukemia Stem Cell Transplantation International
Condition: Acute Lymphoblastic Leukemia
Intervention: Procedure: Transplantation with Stem Cells from Umbilical Cord
12 Recruiting Dose Escalation Trial of WT1-specific Donor-derived T Cells Following T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Relapsed/Refractory Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Drug: busulfan;   Drug: melphalan;   Drug: fludarabine;   Biological: anti-thymocyte globulin (ATG);   Procedure: a T cell depleted stem cell transplant
13 Recruiting Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia
Condition: Leukemia
Interventions: Drug: clofarabine;   Drug: cytarabine;   Drug: daunorubicin hydrochloride;   Drug: decitabine
14 Not yet recruiting Trial to Test the Effects of Adding 1 of 2 New Treatment Agents to Commonly Used Chemotherapy Combinations
Conditions: Acute Myeloid Leukaemia;   Myelodysplastic Syndrome
Interventions: Drug: Arm A Mylotarg;   Drug: Arm D Cladribine;   Drug: AC220;   Drug: Ganetespib
15 Completed
Has Results
MDX-010 Antibody, MDX-1379 Melanoma Vaccine, or MDX-010/MDX-1379 Combination Treatment for Patients With Unresectable or Metastatic Melanoma
Conditions: Melanoma;   Metastases
Interventions: Drug: MDX-010 (anti-CTLA4) monoclonal antibody;   Biological: MDX-1379 (gp100) Melanoma Peptide Vaccine
16 Active, not recruiting
Has Results
Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With AML Leukemia
Condition: Leukemia
Interventions: Biological: sargramostim;   Drug: busulfan;   Drug: cyclophosphamide;   Drug: cytarabine;   Drug: gemtuzumab ozogamicin (GO);   Drug: Daunorubicin;   Procedure: Autologous HCT;   Procedure: Allogeneic HCT
17 Completed Prospective Randomized Study Comparing One or Two High Dose Chemotherapy Regimen Followed by Autologous Stem Cell Transplantation
Condition: Acute Myeloid Leukemia
Interventions: Drug: Zavedos;   Drug: Cerubidine

Indicates status has not been verified in more than two years